Emmaus Life Sciences, Inc 10-Q for FY2026 Q2
Emmaus Life Sciences, Inc. (EMMA)
10-Q
2026-08-14
For: 2026-06-30
View Original
Added on
August 14, 2026
About this 10-Q
Emmaus Life Sciences, Inc filed this 10-Q on August 14, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $6.32M
- up 124.3% from $2.82M a year earlier
- Net income
- $1.34M
- compared with a net loss of $1.14M a year earlier
- Diluted EPS
- $0.02
- compared with -$0.02 a year earlier